Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.
D000172:Acromegaly / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use*; D002117:Calcitriol / Q000627:therapeutic use; D003613:Danazol / Q000627:therapeutic use*; D004715:Endometriosis / Q000188:drug therapy; D012968:Etidronic Acid / Q000627:therapeutic use*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000188:drug therapy; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D007011:Hypoparathyroidism / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007774:Lactation / Q000187:drug effects; D008595:Menorrhagia / Q000188:drug therapy; D010018:Osteomalacia / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy; D011245:Pregnadienes / Q000627:therapeutic use*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D012279:Rickets / Q000188:drug therapy; D014807:Vitamin D / Q000627:therapeutic use*
D006887:Hydroxycholecalciferols; D011245:Pregnadienes; D014807:Vitamin D; D001971:Bromocriptine; D011388:Prolactin; D002117:Calcitriol; D012968:Etidronic Acid; D003613:Danazol; C008088:alfacalcidol